ARWR
Arrowhead Pharmaceuticals, Inc. Earnings
$19.9
Earnings Summary
Revenue | $2.5Mn |
Net Profits | $-173.09Mn |
Net Profit Margins | -6923.4% |
Arrowhead Pharmaceuticals, Inc.’s revenue fell -29.6% since last year same period to $2.5Mn in the Q4 2024. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated +Inf% jump in its revenue since last 3-months.
Arrowhead Pharmaceuticals, Inc.’s net profit fell -30.27% since last year same period to $-173.09Mn in the Q4 2024. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated -1.49% fall in its net profits since last 3-months.
Arrowhead Pharmaceuticals, Inc.’s net profit margin fell -85.04% since last year same period to -6923.4% in the Q4 2024. On a quarterly growth basis, Arrowhead Pharmaceuticals, Inc. has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.72 |
EPS Estimate Current Year | -0.72 |
Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.72 - a 21.54% jump from last quarter’s estimates.
Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -0.72.
Key Ratios
Earning Per Share (EPS) | -1.39 |
Arrowhead Pharmaceuticals, Inc.’s earning per share (EPS) fell -12.1% since last year same period to -1.39 in the Q4 2024. This indicates that the Arrowhead Pharmaceuticals, Inc. has generated -12.1% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-09 | -0.16 | -1.02 | -537.5% |
2024-08-08 | -0.55 | -1.38 | -150.91% |
2025-02-10 | -0.72 | -1.39 | -92.15% |
2024-11-26 | -0.92 | -1.37 | -48.59% |
